Please use a PC Browser to access Register-Tadawul
Get It
EXCLUSIVE: Soligenix Tells Benzinga HyBryte Expanded Treatment Continues To Demonstrate Outcomes In -Early-Stage Cutaneous T-Cell Lymphoma
Soligenix, Inc. SNGX | 2.39 | -2.85% |